Associations of plasma fibroblast growth factor 23 and other markers of chronic kidney disease—Mineral and bone disorder with all-cause mortality in South African patients on maintenance dialysis: A 3-year prospective cohort study-Reference-Cited by-同舟云学术

Associations of plasma fibroblast growth factor 23 and other markers of chronic kidney disease—Mineral and bone disorder with all-cause mortality in South African patients on maintenance dialysis: A 3-year prospective cohort study

Published:2019-05-20 Issue:5 Volume:14 Page:e0216656
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Waziri Bala^ORCID,Musenge Eustasius,Duarte Raquel,Dickens Caroline,Dix-Peek Therese,Rekhviashvili Vakhtang,Paget Graham,Naicker Saraladevi

Funder

AstraZeneca Research Trust Fund

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain;T Yamashita;Biochemical and biophysical research communications,2000

2. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis;OM Gutierrez;The New England journal of medicine,2008

3. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease;OM Gutierrez;Circulation,2009

4. Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality.;M Wolf;Journal of the American Society of Nephrology: JASN,2011

5. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis;OM Gutierrez;Clinical journal of the American Society of Nephrology: CJASN,2010

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum fibroblast growth factor 23 concentration and the risk of mortality in patients undergoing peritoneal dialysis;Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis;2024-03-06

2. Mineral and Bone Disorder in CKD;Management of Kidney Diseases;2023

3. Fibroblast growth factor 23: translating analytical improvement into clinical effectiveness for tertiary prevention in chronic kidney disease;Clinical Chemistry and Laboratory Medicine (CCLM);2022-08-26

4. A predictive risk score to diagnose hypocalcemia after parathyroidectomy in patients with secondary hyperparathyroidism: a 22-year retrospective cohort study;Scientific Reports;2022-06-09

5. Parathyroidectomy Is Associated With Reversed Nondipping Heart Rate That Impacts Mortality in Chronic Kidney Disease Patients;Endocrine Practice;2022-02